Enhanced antibody production through sustained antigen release from biodegradable granules

被引:12
作者
Nakaoka, R [1 ]
Tabata, Y [1 ]
Ikada, Y [1 ]
机构
[1] KYOTO UNIV, BIOMED ENGN RES CTR, SAKYO KU, KYOTO 606, JAPAN
关键词
immunological adjuvant; biodegradable granule; antibody production; sustained release; IL-1; production;
D O I
10.1016/0168-3659(95)00078-X
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A proteinaceous model antigen, ovalbumin (OVA), was incorporated into poly(DL-lactic acid) (PDLLA) granules for sustained release of OVA over about 5 weeks without any large initial burst. When the granules were injected into the mouse peritoneal cavity, the production of anti-OVA IgG antibody in the serum was significantly enhanced and persisted for a long period compared with that induced by injection of OVA in the water-soluble form. Simple mixing of the PDLLA granules with free OVA had no enhancing effect on the antibody response, indicating that OVA incorporation in the granules is essential to enhance IgG production. The secondary response to antibody production was greater for mice given the primary immunization with the OVA-loaded granules than with free OVA. A body distribution study of OVA demonstrated that incorporation of OVA into PDLLA granules reduced its translocation to the blood circulation, leading to prolonged accumulation of OVA in the peritoneal cavity. Macrophages cocultivated with PDLLA granules containing OVA produced a larger amount of interleukin 1 than those cultured with other agents, suggesting that the PDLLA granules effectively activate the cell function for antibody production. It was concluded that the biodegradable granules were useful as a release carrier of antigens to enhance the antibody production.
引用
收藏
页码:215 / 224
页数:10
相关论文
共 36 条
[1]   STRATEGIES FOR EXPLOITING THE IMMUNE-SYSTEM IN THE DESIGN OF VACCINES [J].
ADA, G .
MOLECULAR IMMUNOLOGY, 1991, 28 (03) :225-230
[2]  
ALLISON AC, 1973, CIBA F S IMMUNOPOTEN, V18, P73
[3]   IMMUNE-RESPONSE TO NASAL DELIVERY OF ANTIGENICALLY INTACT TETANUS TOXOID ASSOCIATED WITH POLY(L-LACTIC ACID) MICROSPHERES IN RATS, RABBITS AND GUINEA-PIGS [J].
ALMEIDA, AJ ;
ALPAR, HO ;
BROWN, MRW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) :198-203
[4]   BIODEGRADABLE MICROSPHERES AS CONTROLLED-RELEASE TETANUS TOXOID DELIVERY SYSTEMS [J].
ALONSO, MJ ;
GUPTA, RK ;
MIN, C ;
SIBER, GR ;
LANGER, R .
VACCINE, 1994, 12 (04) :299-306
[5]   SYNTHETIC PEPTIDES AS THE BASIS FOR VACCINE DESIGN [J].
ARNON, R .
MOLECULAR IMMUNOLOGY, 1991, 28 (03) :209-215
[6]   TOLERANCE TO RAT MONOCLONAL-ANTIBODIES - IMPLICATIONS FOR SEROTHERAPY [J].
BENJAMIN, RJ ;
COBBOLD, SP ;
CLARK, MR ;
WALDMANN, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (06) :1539-1552
[7]  
ELDRIDGE JH, 1993, SEMIN HEMATOL, V30, P16
[8]   BIODEGRADABLE AND BIOCOMPATIBLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES AS AN ADJUVANT FOR STAPHYLOCOCCAL ENTEROTOXIN-B TOXOID WHICH ENHANCES THE LEVEL OF TOXIN-NEUTRALIZING ANTIBODIES [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
TICE, TR ;
GILLEY, RM .
INFECTION AND IMMUNITY, 1991, 59 (09) :2978-2986
[9]   CONTROLLED VACCINE RELEASE IN THE GUT-ASSOCIATED LYMPHOID-TISSUES .1. ORALLY-ADMINISTERED BIODEGRADABLE MICROSPHERES TARGET THE PEYERS PATCHES [J].
ELDRIDGE, JH ;
HAMMOND, CJ ;
MEULBROEK, JA ;
STAAS, JK ;
GILLEY, RM ;
TICE, TR .
JOURNAL OF CONTROLLED RELEASE, 1990, 11 (1-3) :205-214
[10]  
EPPSTEIN DA, 1986, DELIVERY SYSTEMS PEP, P277